| arznei-telegramm® 09/2015 |
ADDENDUM |
| "Unchanged" drugs in the faeces |
SPOT ON |
| Shortages of drugs and vaccines |
NEW ON THE MARKET |
| Insulin glargine biosimilar ABASAGLAR |
| Edoxaban (LIXIANA) in the treatment of atrial fibrillation and venous thromboembolism |
REVIEW |
| VEGF inhibitors (II): treatment of retinal vein occlusion |
a-t READER'S QUESTIONS AND COMMENTS |
| D-mannose against urinary tract infections? |
| Medical in-fighting: new anticoagulants versus coumarins |
IN BRIEF |
| Preventive consumer protection by the German Act on the Reform of the Market for Medicinal Products (AMNOG) |
CURRENT ADR NETWORK REPORT | Herpes zoster following chickenpox vaccination |
SIDE EFFECTS |
| Severe disabling joint pain with gliptins |
| Fusafungine (LOCABIOSO): EMA reassesses risk-benefit ratio |
| Suicidal thoughts with prucalopride |
e a-t IN THE INTERNET |
| "Flu" vaccines 2015/2016 |